-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TeKWjn3OrDoPWwGUFQ10LLsD6yriqgvYSWHtueMCY9XXvxVp5Rf7IpTZygvsOIqc Fa2+FZPVsAmoAlCLyJ/i6Q== 0000950144-02-001109.txt : 20020414 0000950144-02-001109.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950144-02-001109 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020207 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20020211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 02532644 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD STREET 2: STE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 6156651283 MAIL ADDRESS: STREET 1: ONE BURTON HILLS BLVD. STREET 2: SUITE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g74143e8-k.htm AMSURG CORP. e8-k
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 8, 2002 (February 7, 2002)

AMSURG CORP.
(Exact Name of Registrant as Specified in its Charter)

         
Tennessee   000-22217   62-1493316
(State or other jurisdiction of   (Commission   (I.R.S. employer
incorporation or organization)   File Number)   identification no.)
     
20 Burton Hills Boulevard    
Nashville, Tennessee   37215
(Address of principal executive offices)   (Zip code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former name or former address, if changed since last report)

 


Item 7. Financial Statements and Exhibits.
Item 9. Regulation FD Disclosure
SIGNATURES
INDEX TO EXHIBITS
PRESS RELEASE


Table of Contents

Item 7. Financial Statements and Exhibits.

     (c)  Exhibits:

     
99   Press release dated February 7, 2002

Item 9. Regulation FD Disclosure

     A press release issued by AmSurg Corp. on February 7, 2002 is attached hereto as Exhibit 99.

2


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    AMSURG CORP.
 
       
 
    By:   /s/ Claire M. Gulmi

Claire M. Gulmi
 
        Senior Vice President and Chief Financial Officer
(Principal Financial and Duly Authorized Officer)

Date: February 8, 2002

3


Table of Contents

INDEX TO EXHIBITS

     
Exhibit    
Number   Description

 
99   Press release dated February 7, 2002

4 EX-99 3 g74143ex99.txt PRESS RELEASE EXHIBIT 99 PRESS RELEASE AMSURG CORP. TO BROADCAST FOURTH QUARTER CONFERENCE CALL LIVE ON THE INTERNET NASHVILLE, Tenn. (February 7, 2002) - AmSurg Corp. (Nasdaq/NM: AMSG) today announced it will provide an on-line Web simulcast and rebroadcast of its 2001 fourth quarter earnings release conference call. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to www.amsurg.com and clicking on the link to Investor Relations or at www.streetevents.com. The call is scheduled to begin at 4:15 p.m. eastern time on February 19, 2002. The on-line replay will follow shortly after the call and continue for seven days. AmSurg Corp. develops, acquires and manages physician practice-based ambulatory surgery centers and specialty physician networks in partnership with surgical and other group practices. At September 30, 2001, AmSurg owned a majority interest in 92 centers and had three centers under development. Contact: Claire M. Gulmi, Senior Vice President and Chief Financial Officer (615) 665-1283 -----END PRIVACY-ENHANCED MESSAGE-----